Erratum: Co-administration of pentoxifylline and thiopental causes death by acute pulmonary oedema in rats (British Journal of Pharmacology (2006) 149, (450-455) DOI: 10.1038/sj.bjp.0706871);Co-administration of pentoxifylline and thiopental causes death by acute pulmonary oedema in rats

British Journal of Pharmacology

Volumn 149, Issue 4, 2006, Pages 450-455

  Pereda, J ^a   Gomez Cambronero L ^a   Alberola, A ^a   Fabregat, G ^b   Cerda M ^c   Escobar, J ^a   Sabater, L ^b   Garcia De La Asuneion J ^b   Via J ^a   Sastre, J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Universitary Clinic Hospital   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Drug interaction; Hypoxemia; Lung oedema; Pentoxifylline; Thiopental; Vascular permeability

Indexed keywords

KETAMINE; PENTOXIFYLLINE; THIOPENTAL;

ACUTE PANCREATITIS; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD VESSEL PERMEABILITY; CAUSE OF DEATH; CONTROLLED STUDY; DEATH; HEART FAILURE; HEMODYNAMICS; HISTOPATHOLOGY; HYPOXEMIA; LUNG BLOOD VESSEL; LUNG EDEMA; MALE; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RESPIRATORY FAILURE;

EID: 33750058896     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707127     Document Type: Erratum

References (22)

1. Ambrisko TD, Nemeth T (2004). A computer program for calculation of doses and prices of injectable medications based on body weight or body surface area. Can J Vet Res 68: 62-65.
2. Avram MJ, Sanghvi R, Henthorn TK, Krejcie TC, Shanks CA, Fragen RJ et al. (1993). Determinants of thiopental induction dose requirements. Anesth Analg 76: 10-17.
3. Baughman RP, Lower EE, Du Bois RM (2003). Sarcoidosis. Lancet 361: 1111-1118.
4. British National Formulary (1995). British Medical Association. Royal Pharmaceutical Society of Great Britain: 11, London.
5. Castillo C, Asbun J, Escalante B, Villalon CM, López P, Castillo EF (1999). Thiopental inhibits nitric oxide production in rat aorta. Can J Physiol Pharmacol 77: 858-966.
6. Fischer S, Renz D, Schaper W, Karliczek GF (1998). Barbiturates decrease the expression of vascular endothelial growth factor in hypoxic cultures of porcine brain derived microvascular endothelial cells. Brain Res Mol Brain Res 60: 89-97.
7. Frazier DL, Price GS (1998). Use of body surface area to calculate chemotherapeutic drug dose in dogs: II. Limitations imposed by pharmacokinetic factors. J Vet Intern Med 12: 272-278.
8. Galley HF, Nelson LR, Webster NR (1995). Anesthetic agents decrease the activity of nitric oxide synthase from human polymorphonuclear leucocytes. Br J Anaesth 75: 326-329.
9. Galley HF, Webster NR (1996). Brain nitric oxide synthase activity is decreased by intravenous anesthetics. Anesth Analg 83: 591-594.
10. Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B et al. (1997). Targeted disruption of the β-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Inv 100: 2022-2027.
11. Gómez-Cambronero LG, Camps B, García De La Asunción J, Cerdá M, Pellín A, Pallardó FV et al. (2000). Pentoxifylline ameliorates caerulein-induced pancreatitis in rats. Role of glutathione and nitric oxide. J Pharmacol Exp Ther 293: 670-676.
12. Lack JA, Stuart-Taylor ME (1997). Calculation of drug dosage and body surface area of children. Br J Anaesth 78: 601-605.
13. Martindale's Pharmacopoeia (1989). Martindale: The Extra Pharmacopoeia. The Pharmaceutical Press: London.
14. Morris J, Cook TM (2001). Rapid sequence induction: a national survey of practice. Anaesthesia 56: 1090-1097.
15. O'Donovan DA, Kelly CJ, Abdih H, Bouchier-Hayes D, Watson RW, Redmond HP et al. (1995). Role of nitric oxide in lung injury associated with experimental acute pancreatitis. Br J Surg 82: 1122-1126.
16. Oliveira-Junior IS, Pinheiro BV, Silva IDCG, Salomao R, Zollner RL, Beppu OS (2003). Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume. Braz J Med Biol Res 36: 1349-1357.
17. Pereda J, Sabater L, Cassinello N, Gómez-Cambronero L, Closa D, Folch E et al. (2004). Treatment of experimental acute pancreatitis by simultaneous inhibition of TNF-α production and xanthine oxidase activity. Role of MAP kinases. Ann Surg 240: 108-116.
18. Reves JG, Glass PSA, Lubarsky DA, McEvoy MD (2005). Intravenous nonopioid anesthetics, Chapter 10. In: Miller RD (ed). Miller's Anesthesia, Vol. A. 6th edn, Philadelphia: Elsevier, pp 317-378.
19. Robertson CS, Basran GS, Hardy JG (1988). Lung vascular permeability in patients with acute pancreatitis. Pancreas 3: 162-165.
20. Schandené L, Vandenbussche P, Crusiaux A, Alegre ML, Abramowicz D, Dupont E et al. (1992). Differential effects of pentoxifylline on the production of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) by monocyte and T cells. Immunology 76: 30-34.
21. Takenaka K, Nishimura Y, Nishiuma T, Sakashita A, Yamashita T, Kobayashi K et al. (2006). Ventilator-induced lung injury is reduced in transgenic mice that overexpress endothelial nitric oxide synthase. Am J Physiol 290: L1078-L1086.
22. Ward A, Clissold SP (1987). Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34: 50-97.